Indonesia investigates new H5N1 source, as case-fatality soars:
This article was originally published in Clinica
Executive Summary
Indonesia is investigating the source of exposure of a fatal case of H5N1 avian flu from Tangerang, Banten province, according to an August 16 WHO update, citing the health ministry. To date, of the country's 104 officially-confirmed cases, 83 (80%) have been fatal. Indonesia's case-fatality rate is increasing far above the average of other countries: of this year's 29 officially-recorded cases, 25 have been fatal, equating to 86% case-fatality. In the rest of the world, of this year's 29 cases, 11 were fatal (38%); and of the 217 cases recorded since 2003, 111 were fatal (51%).
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.